New developments in the management of ER-positive metastatic breast cancer
Unlocking the pathways of endocrine resistance
Date
07 Oct 2016Session
New developments in the management of ER-positive metastatic breast cancerPresenters
Giuseppe CuriglianoAuthors
G. CuriglianoAuthor affiliations
- Drug Development, Istituto Europeo di Oncologia, 20141 - Milano/IT
Resources
Login to access the resources on OncologyPRO.
If you do not have an ESMO account, please create one for free.
Resources from the same session
Minimising the toxicities of targeted therapies
Presenter: Thomas Bachelot
Session: New developments in the management of ER-positive metastatic breast cancer
Resources:
Slides